back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-103,553 vol |
409,837 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-143,975.52
-369,168 vol $0.39 each |
462,674 | |
| Filed 2018-06-06 Tx date 2018-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$143,975
+369,168 vol $0.39 each |
877,318 | |
| Filed 2018-06-06 Tx date 2018-06-04 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-58,589.6166
-156,573 vol $0.3742 each |
720,745 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-18,296.2692
-36,396 vol $0.50 each |
831,842 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,296
+36,396 vol $0.50 each |
522,114 | |
| Filed 2018-05-16 Tx date 2018-05-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,261.28
-13,964 vol $0.52 each |
508,150 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$37,901
+20,711 vol $1.83 each |
495,457 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,556.30
-9,739 vol $1.70 each |
485,718 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-37,901.13
-20,711 vol $1.83 each |
868,238 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+238,714 vol |
513,390 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,439.8706
-1,906 vol $1.28 each |
474,746 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-494,686.46
-369,169 vol $1.34 each |
888,949 | |
| Filed 2017-06-06 Tx date 2017-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$494,686
+369,169 vol $1.34 each |
636,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,875
-25,000 vol $1.27 each |
611,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,750
-25,000 vol $1.27 each |
586,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,250
-25,000 vol $1.29 each |
561,652 | |
| Filed 2017-06-06 Tx date 2017-06-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-108,800
-85,000 vol $1.28 each |
476,652 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+126,158 vol |
178,750 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+109,190 vol |
1,258,118 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+171,123 vol |
274,676 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,930.25
-7,025 vol $2.41 each |
267,483 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-46,597.50
-20,710 vol $2.25 each |
1,148,928 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$46,597
+20,710 vol $2.25 each |
275,308 | |
| Filed 2017-03-22 Tx date 2017-03-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,928.08
-800 vol $2.41 each |
274,508 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,920
+20,000 vol $2.55 each |
254,598 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$647,499
+163,098 vol $3.97 each |
234,598 | |
| Filed 2016-06-07 Tx date 2016-06-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,465,596.96
-369,168 vol $3.97 each |
1,169,638 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$249,470
+71,500 vol $3.49 each |
71,500 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,592 vol |
52,592 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+103,553 vol |
103,553 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+62,132 vol |
1,538,806 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1,476,674 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Koven, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,476,674 |